Choice of Serum Markers in Antenatal Screening for Down's Syndrome

Wald NJ Cuckle HS Densem JW Maternal serum screening for Down's syndrome in early pregnancy. BMJ, 1988;297:883–7.

Wald NJ Densem JW Smith D Klee GG. Four marker serum screening for Down's syndrome. Prenat Diagn., In press.

Wald N Wald K Smith D . The extent of Down's syndrome screening in Britain in 1991. Lancet, 1992;340:494.

Cuckle H Nanchahal K Wald N . Birth prevalence of Down's syndrome in England and Wales. Prenat Diagn, 1991;11:29–34.

Mutton DE Ide R Alberman E Bobrow M . Analysis of national register of Down's syndrome in England and Wales: Trends in prenatal diagnosis, 1989–91. BMJ, 1993;306:431–2.

Wald NJ Kennard A Densem JW Cuckle HS Chard T Butler L . Antenatal maternal serum screening for Down's syndrome: Results of a demonstration project. BMJ, 1992;305:391–4.

Cheng EY Luthy DA Zebelman AM Williams MA Lieppman RE Hickok DE. A prospective evaluation of a second trimester screening test for Down's syndrome using maternal serum alpha-fetoprotein, hCG and unconjugated oestriol. Obstet Gynecol, 1993;81:72–7.

Haddow JE Palomaki GE Knight GJ Prenatal screening for Down's syndrome with use of maternal serum markers. JV Engl J Med, 1992;327:588–93.

Goodburn SF Yates JRW Praggatt PR Second trimester maternal scrum screening using alphafetoprotcin, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programme. Prenat Diagn., In press.

Wald NJ Kennard A Watt HC Smith D . Value of maternal serum unconjugated oestriol measurement in prenatal screening for Down's syndrome. Prenat Diagn., In press.

Tabor A Philip J Madsen M Bang J Obel EB Pederson B. Norgaard Randomised controlled trial of genetic amnio centesis in 4606 low-risk women. Lancet, 1986;1:1287–93.